Article
Envision Pharma Group
Medical Affairs- So Far to Come... So Far to Go
Summary
In this episode, Tom Caravela and Mandy Krumnow explore the evolving landscape of medical affairs, highlighting its value and impact. They discuss what constitutes "true impact" within the field, supported by case studies showcasing successful initiatives. The conversation covers technological advancements and the challenges medical affairs faces, as well as future trends. Mandy shares insightful interview tips for candidates and emphasizes the influence of medical affairs in corporate decision-making. The episode also offers leadership advice for professionals in the field, concluding with encouraging words for the MSL community and expressions of gratitude.
Key Points
- Medical affairs has evolved from a reactive support function to a strategic partner responsible for evidence generation, medical communications, and shaping scientific narratives. The increasing complexity of therapies and the proliferation of healthcare information necessitate a consultative approach, making medical affairs crucial in informing patient care and improving outcomes. Future medical affairs leaders will need to prioritize resilience, patient centricity, and strategic thinking, hiring for capabilities that align with these goals rather than traditional academic credentials alone.
medical affairs, strategic partner, evidence generation, medical communications, patient centricity, healthcare information, future trends
Related Topics
You May Also Like
Envision Pharma Group
Article
Envision Pharma Group
Medical affairs: The power behind redefining commercialization
Podcast
MSL Talk: Tom Caravela, Carsten Schnatwinkel, Jeanna Cooper
The Struggle With KOL Access in Todays World
Podcast
MSL Talk: Tom Caravela, Daniel Snyder
Interim Impact The Rise of Fractional Medical Affairs Roles in Pharmas New Reality
Article
S.F. Oosting, J. Barriuso, A. Bottomley, M. Galotti, B. Gyawali, B. Kiesewetter, N.J. Latino, F. Martinelli, M. Pe, G. Pentheroudakis, F. Roitberg, H. Vachon, E.G.E. de Vries, M. Piccart, N.I. Cherny
Methodological and reporting standards for quality-of-life data eligible for European Society for Medical Oncology-Magnitude of Clinical Benefit Scale
Article
Dylan V Neel, David S Shulman, Clement Ma, Florence Bourgeois, Steven G DuBois